BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230729T120000
DTEND;TZID=America/New_York:20230729T130000
DTSTAMP:20261012T024456
CREATED:20230608T212450Z
LAST-MODIFIED:20230608T212450Z
UID:3486935-1690632000-1690635600@patientworthy.com
SUMMARY:The MDS Foundation's Updates from the 17th International Congress on MDS: Promising Treatment Advances
DESCRIPTION:Updates from the 17th International Congress on MDS: Promising Treatment Advances\nJuly 29\, 2023 \nIn this webinar\, Dr. Moshe Mittelman will provide an overview of the most promising research presented at the 2023 17th International Congress on Myelodysplastic Syndromes impacting MDS diagnosis\, prognosis\, and management. After the presentation\, there will be a Q & A session for participants. \nSpeaker: Moshe Mittelman MD; Professor of Medicine and Hematology\, Tel Aviv Sourasky Medical Center \nTo register\, click here.\n 
URL:https://patientworthy.com/event/mds-foundations-updates-17th-international-congress-advances/
CATEGORIES:Myelodysplastic Syndromes
ORGANIZER;CN="The%20MDS%20Foundation":MAILTO:patientliaison@mds-foundation.org
END:VEVENT
END:VCALENDAR